Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FXSGW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,953
Award facts
- Contract value 100% obligated
- $18,953.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) valued at $18,953.21 under a firm fixed-price contract. This non-set-aside award was executed on November 12, 2025, with an ultimate completion date of November 13, 2025, and performance undertaken at the contractor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and veteran healthcare settings, aligning with the Defense Logistics Agency's mission to support the Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a billion-dollar vehicle valued at $999,999,999.00 that extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a wide range of pharmaceutical products and medical commodities to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability in fulfilling federal medical procurement requirements through competitive awards across multiple therapeutic domains, including specialty medications, generic drugs, and medical supplies supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FXSGW?
SPE2DB26FXSGW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FXSGW worth?
The government has obligated $18,953 on SPE2DB26FXSGW.
Is contract SPE2DB26FXSGW an order under another contract?
Yes. SPE2DB26FXSGW is a delivery order under SPE2DB25D7060, an indefinite delivery contract.
Was contract SPE2DB26FXSGW competed?
The extent of competition for SPE2DB26FXSGW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award